Understanding Patient Outcomes
The following stories are anonymized accounts from individuals who have participated in our NIH-registered clinical studies. These patient experiences provide insight into the potential of neuroregeneration and ocular repair.
Important Note: These summaries reflect individual experiences within investigational protocols. Individual results vary, and these accounts are not intended to imply a guarantee of outcome or a medical treatment.
Vision Improvement Stories (SCOTS 2)
The Stem Cell Ophthalmology Treatment Study 2 (SCOTS 2) focuses on treating degenerative vision loss. These summaries reflect observations made through independent ophthalmic testing.
Before joining the SCOTS 2 study, R.W. experienced significant difficulty navigating daily environments due to advanced optic nerve atrophy.
- The Experience: R.W. underwent the autologous bone-marrow–derived stem cell protocol with a focus on retrobulbar delivery.
- Observed Changes: Following the procedure, independent testing showed a measurable expansion in visual fields. The patient reported a greater ability to detect movement and objects in their periphery, providing a renewed sense of independence.
Case Study: Optic Nerve Atrophy (Patient R.W.)
D.O. sought options for stabilizing vision loss caused by "dry" AMD, which had begun to impact their ability to read and recognize faces.
- The Experience: D.O. participated in the SCOTS 2 study using a combination of intravenous and localized ocular delivery.
- Observed Changes: Post-study evaluations indicated a stabilization of central vision. D.O. reported improved contrast sensitivity and "clearer" central vision, allowing for more comfortable engagement with daily reading tasks.
Case Study: Age-Related Macular Degeneration (Patient D.O.)
Neurologic Improvement Stories (NEST)
The Neurologic Stem Cell Treatment Study (NEST) evaluates how cellular therapy may support patients with movement, cognitive, and vascular neurologic disorders.
M.S. entered the NEST study primarily concerned with increasing tremors and a loss of balance that led to frequent falls.
The Experience: The patient received the dual-delivery protocol (Intravenous and Intranasal) to maximize cellular access to the central nervous system.
Observed Changes: M.S. reported a noticeable reduction in the severity of "off" periods. Study observations included improved gait stability and better fine motor control, allowing for easier completion of tasks like buttoning a shirt and handwriting.
Case Study: Parkinson’s Disease (Patient M.S.)
Years after a stroke, K.L. faced persistent cognitive fatigue and limited mobility in their right side.
- The Experience: Following a thorough eligibility review, K.L. underwent the NEST protocol focusing on neuroprotection and inflammation reduction.
- Observed Changes: The patient reported a significant improvement in "cognitive clarity" and a reduction in brain fog. Physical assessments noted a gradual improvement in strength and coordination in the affected limbs.
Case Study: Stroke Recovery / CVA (Patient K.L.)
How We Document Results
At MD Stem Cells, we believe in the ethical and transparent reporting of data. The stem cell treatment results shared on this page are compiled from:
Self-Reported Patient Data
Insights into daily quality-of-life changes.
Independent Specialist Evaluations
Measurements provided by the patient’s local neurologists or ophthalmologists.
Clinical Study Baseline Comparison
Comparing post-procedure function against initial baseline tests conducted on Day 1 of the study.
Compliance & Transparency Statement
It is important for all prospective participants to understand that MD Stem Cells operates within a clinical research framework.
All treatments are investigational.
-
These procedures are not part of the FDA-approved "standard of care."
-
We provide these stories to illustrate the potential of our protocols, not to serve as a universal expectation of success.
Explore Your Eligibility
Your medical journey is unique. To determine if your diagnosis qualifies you for enrollment in the SCOTS 2 or NEST clinical studies, please begin our formal review process.
Our Eligibility Insights
Discover how our clinical study participants experienced investigational treatments and see if your story could be next—find out if you qualify today.